Stay updated with breaking news from Peter Nell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mana.bio's first-of-its-kind AI platform discovers and optimizes novel, customizable LNPs for tissue-specific delivery of nucleic acid-based therapeutics and vaccinesLed by a multidisciplinary team with expertise in drug delivery, nanotechnology, and
/PRNewswire/ -- Mana.bio, a biotechnology company accelerating programmable drug delivery, today unveiled its AI-based lipid nanoparticle (LNP) delivery...
Bayer, Mammoth announce novel gene editing technology partnership
Agreement strengthens Bayer's new cell and gene therapy platform further Supports Mammoth's vision of unlocking the full potential of novel CRISPR sys
Bayer will pay Mammoth Biosciences $40 million to work on CRISPR-based gene-editing technologies in four different diseases.